Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine
Molecules · 2023
DOI: 10.3390/molecules28010396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Darya Pon Kina und 8 weiteren Autor:innen. Beteiligte Einrichtung: N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., Novos…. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Liver Diseases. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Russian Science Foundation.
Abstract (Originalsprache)
Free fatty acid receptor-1 (FFAR1) is one of the possible therapeutic targets in the search for new hepatoprotective drugs. FFAR1 agonists were found to have hypolipidemic, antifibrotic, anti-inflammatory, antiproliferative and antioxidant effects in addition to hypoglycemic action. In this work, we conducted a study of the hepatoprotective effect of the compound QS-528 (previously discovered as an agonist of FFAR1) at doses of 60, 90, 120 and 150 mg/kg on carbon tetrachloride (CCl4)-induced liver injury. At the end of the experiment, a biochemical blood assay demonstrated that the introduction of QS-528 dose-dependently reduces the levels of liver enzymes (AST, ALT and ALKP). Histological and morphometric studies of animals’ livers treated with QS-528 at doses of 120 and 150 mg/kg showed a decrease in degenerative/necrotic changes in hepatocytes and an increase in the regenerative activity of the liver. In addition, no toxicity at a single oral dose of 1000 mg/kg and an increase in HepG2 cell viability in vitro were found. Thus, the compound QS-528 was found to exhibit a hepatoprotective effect against CCl4-induced toxic liver damage.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- N. N. Vorozhtsov Novosibirsk Institute of Organic Chemistry, Siberian Branch of the Russian Academy of Sciences, 9, Akademika Lavrentieva Ave., Novosibirsk 630090, Russia.
ORCID-Profile: Mikhail Khvostov, Yulia Meshkova, Mariya Marenina, Olga Luzina
Förderung
- Russian Science Foundation
Zitieren
APA
Pon Kina, D., Kuranov, S., Khvostov, M., Zhukova, N., Meshkova, Y., Marenina, M., Luzina, O., Tolstikova, T., & Salakhutdinov, N. (2023). Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine. Molecules. https://doi.org/10.3390/molecules28010396
Vancouver
Pon Kina D, Kuranov S, Khvostov M, Zhukova N, Meshkova Y, Marenina M, et al. Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine. Molecules. 2023. doi:10.3390/molecules28010396
BibTeX
@article{PonKina2023,
author = {Pon Kina, Darya and Kuranov, Sergey and Khvostov, Mikhail and Zhukova, Nataliya and Meshkova, Yulia and Marenina, Mariya and Luzina, Olga and Tolstikova, Tatyana and Salakhutdinov, Nariman},
title = {Hepatoprotective Effect of a New FFAR1 Agonist—N-Alkylated Isobornylamine},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28010396}
}
EUVIMED